Back to results
US 12,688,916 B2Granted
Biomarker based nicotine replacement therapy
AssigneeMcNeil Corporation
InventorsJustin Mellinger, Ryan Walsh, Sophie Edgar, Ming Dong, Curt Binner
Life of this patent
Estimating the term…
Abstract
A device for providing nicotine replacement therapy may be provided. The device may comprise a processor. The processor may be configured to perform one or more actions. A cessation program for a user may be determined. A program intervention event based on a phase of the cessation program may be determined. A marker associated with the user may be determined. A modification to the cessation program may be determined based on the program intervention event.
Claims16
A device for providing nicotine replacement therapy, the device comprising:
- a motion sensor for generating a first digital signal that indicates one or more motions associated with a user;
- a receiver for receiving a second digital signal from a nicotine formulation dispenser, wherein the nicotine formulation dispenser comprises a lockout mechanism;
- and
- a processor, the processor configured to:
- determine a nicotine formulation consumption rate associated with the user based on the second digital signal from the nicotine formulation dispenser;
- determine a smoking detection event when a carbon monoxide saturation level for the user exceeds a threshold;
- determine a rate of cigarette consumption using the smoking detection event;
- determine a fidgeting motion using the first digital signal, wherein the fidgeting motion is predictive of the smoking detection event;
- determine an anticipated craving time based on the fidgeting motion, the nicotine formulation consumption rate, and the rate of cigarette consumption;
- determine an amount of nicotine formulation to reduce a nicotine craving;
- determine a modification to a cessation program based on the anticipated craving time;
- send a third digital signal to the nicotine formulation dispenser to cause the lockout mechanism to move to an operative position, such that the nicotine formulation dispenser can dispense the amount of nicotine formulation to the user at the anticipated craving time to reduce the nicotine craving;
- and
- send a notification message to the user at the anticipated craving time, wherein the notification message instructs the user to dispense the amount of nicotine formulation from the nicotine formulation dispenser.
11 more elements
A device for providing nicotine replacement therapy, the device comprising:
- a motion sensor for generating a first digital signal that indicates one or more motions associated with a user;
- a receiver for receiving a second digital signal from a nicotine formulation dispenser, wherein the nicotine formulation dispenser comprises a lockout mechanism;
- a processor, the processor configured to:
- determine a biomarker associated with a user;
- determine a nicotine formulation consumption rate associated with the user based on the second digital signal from the nicotine formulation dispenser;
- determine a smoking detection event when a carbon monoxide saturation level for the user exceeds a threshold;
- determine a rate of cigarette consumption using the smoking detection event;
- determine a fidgeting motion using the first digital signal, wherein the fidgeting motion is predictive of the smoking detection event;
- determine an anticipated craving time based on the fidgeting motion, the nicotine formulation consumption rate, and the rate of cigarette consumption;
- detect a nicotine craving using the anticipated craving time and the biomarker associated with the user;
- determine an amount of nicotine formulation to reduce the nicotine craving;
- send a third digital signal to the nicotine formulation dispenser to cause the lockout mechanism to move to an operative position such that the nicotine formulation dispenser can dispense the amount of nicotine formulation to the user at the anticipated craving time to reduce the nicotine craving;
- and
- provide an intervention to the user based on the nicotine craving, wherein the intervention comprises a notification message that instructs the user to dispense the amount of nicotine formulation from the nicotine formulation dispenser at the anticipated craving time.
11 more elements
A device for providing nicotine replacement therapy, the device comprising:
- a motion sensor for generating a first digital signal that indicates one or more motions associated with a user;
- a receiver for receiving a second digital signal from a nicotine formulation dispenser, wherein the nicotine formulation dispenser comprises a lockout mechanism;
- and
- a processor, the processor configured to:
- determine a nicotine formulation consumption rate associated with the user based on the second digital signal from the nicotine formulation dispenser;
- determine a smoking detection event when a carbon monoxide saturation level for the user exceeds a threshold;
- determine a rate of cigarette consumption using the smoking detection event;
- determine a fidgeting motion using the first digital signal, wherein the fidgeting motion is predictive of the smoking detection event;
- determine an anticipated craving time based on the fidgeting motion, the nicotine formulation consumption rate, and the rate of cigarette consumption;
- determine a duration for a phase of a cessation program based on the anticipated craving time and the rate of cigarette consumption;
- determine an amount of nicotine formulation to reduce a nicotine craving;
- determine a modification to a cessation program based on the anticipated craving time, the phase, and the duration;
- send a third digital signal to the nicotine formulation dispenser to cause the lockout mechanism to move to an operative position such that the nicotine formulation dispenser can dispense the amount of nicotine formulation to the user at the anticipated craving time to reduce the nicotine craving;
- and
- send a notification message to the user at the anticipated craving time, wherein the notification message instructs the user to dispense the amount of nicotine formulation from the nicotine formulation dispenser.
12 more elements
A device for providing nicotine replacement therapy, the device comprising:
- a motion sensor for generating a first digital signal that indicates one or more motions associated with a user;
- a receiver for receiving a second digital signal from a nicotine formulation dispenser;
- a processor, the processor configured to:
- determine a carbon monoxide saturation level for the user;
- determine a nicotine formulation consumption rate associated with the user based on the second digital signal from the nicotine formulation dispenser;
- determine a smoking detection event when the carbon monoxide saturation level exceeds a threshold;
- determine fidgeting motion using the first digital signal, wherein the fidgeting motion is predictive of the smoking detection event;
- determine an anticipated craving time based on the fidgeting motion, the nicotine formulation consumption rate, and a rate of cigarette consumption;
- determine an amount of nicotine formulation to reduce a nicotine craving;
- send a third digital signal to the nicotine formulation dispenser to cause a lockout mechanism to move to an operative position such that the nicotine formulation dispenser can dispense the amount of nicotine formulation to the user at the anticipated craving time to reduce the nicotine craving;
- and
- send a notification message to the user at the anticipated craving time, wherein the notification message instructs the user to dispense the amount of nicotine formulation from the nicotine formulation dispenser.
9 more elements
Dependencies are inferred from the claim text.